AI Score

Unlock

Novavax Inc. (NVAX)

AI Score

Unlock

6.01

-0.40 (-6.24%)

At close: Apr 01, 2025, 3:59 PM

6.11

1.58%

Pre-market: Apr 02, 2025, 04:44 AM EDT

-6.24% (1D)

Bid	6.09
Market Cap	967.48M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
EPS (ttm)	-1.23
PE Ratio (ttm)	-4.89
Forward PE	20.61
Analyst	Hold

Ask	6.12
Volume	4,799,833
Avg. Volume (20D)	4,291,800
Open	6.41
Previous Close	6.41
Day's Range	6.00 - 6.43
52-Week Range	3.81 - 23.86
Beta	2.91

About NVAX

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...

[Read more]

Industry Biotechnology

Sector Healthcare

IPO Date Dec 5, 1995

Employees 952

Stock Exchange NASDAQ

Ticker Symbol NVAX

Website https://www.novavax.com

Full Company Profile

Analyst Forecast

According to 6 analyst ratings, the average rating for NVAX stock is "Hold." The 12-month stock price forecast is $18.5, which is an increase of 207.56% from the latest price.

Stock Forecasts

Next Earnings Release

Novavax Inc. is scheduled to release its earnings on May 9, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-2.25%

Shares of vaccine stocks are trading lower on repo... Unlock content with Pro Subscription

1 month ago

+17.99%

Novavax shares are trading higher after the company reported better-than-expected Q4 revenue results.

News

1 day ago · zacks.com

Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.

The decline in biotech stocks comes after FDA official Peter Marks' resignation, citing irreconcilable differences with the new HHS Secretary.

2 days ago · youtube.com

Vaccine stocks fall following FDA resignation

Dr. Kavita Patel joins 'Fast Money' to talk the impact of FDA and HHS changes on vaccines, public health policy, and more.

2 days ago · fastcompany.com

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views

Stocks of major vaccine makers dropped on Monday after the Food and Drug Administration's (FDA) top vaccine official Dr. Peter Marks resigned, citing conflicts with Health and Human Services (HHS) Sec...

2 days ago · nypost.com

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official was forced to resign, the most high-profile exit at the regulator as the Trump admin...

1 day ago · cnbc.com

Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.

Shares of vaccine makers Moderna and Novavax, along with a range of other biotech companies, fell after the resignation of key FDA official Peter Marks. Marks stepped down in protest of Health and Hum...

1 day ago · zacks.com

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

2 days ago · reuters.com

Biotech stocks tumble on reports FDA's top vaccine regulator to leave

Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine official at the U.S. Food and Drug Administration had resigned, fanning worries over slowe...